Press Releases and Articles

• August 2010

  Sequella and University of Maryland Restate Exclusive License for Jointly-owned Event Marker System Technology (pdf)

• July 2010

  Two New Tuberculosis (TB) Drugs Show Significant Synergy In Vitro (pdf)

• November 2009

  Sequella and NIH Sign Exclusive Worldwide Licensing Agreement for SQ109 for New Infectious Disease Indications (pdf)

• October 2009

  Sequella Obtains Funding to Continue Expansion of its Anti-infectives Pipeline (pdf)

  Sequella Receives American Recovery and Reinvestment Funding through the NIH (pdf)

• July 2009

  Camping out for biotech tax credits

• June 2009

  Woman CEO's Proving Glass Ceiling Can be Broken (pdf)

• May 2009

  RPM Reports May 30, 2009 Article -- "Conspicuous Consumption: FDA Makes TB a Priority" (pdf)

  Sequella Commences Phase IB Study for New Tuberculosis Drug, SQ109 (pdf)

• March 2009

  Statement From Sequella CEO, Dr. Carol Nacy at the “Stop TB” Meeting in Brazil on the Eve of World TB Day (pdf)

  Sequella to Present at Upcoming European Conferences (pdf)

• February 2009

  2009 Statement from Marty Zug, CFO for Sequella Regarding Biotech Tax Credit Day in Annapolis (pdf)

  Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609 (pdf)

• January 2009

  Sequella Featured in Genetic Engineering News

  Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program (pdf)

• November 2008

  Sequella’s Drug Compliance Monitor Featured in Pharmaceutical Executive’s “Tech Toys” column – November 2008 (pdf)

• October 2008

  Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207 (pdf)

  Sequella to Present Major Developments at International Infectious Disease Meeting (pdf)

• September 2008

  Sequella Receives $2.3 Million NIH Grant for Development of Tuberculosis Antibiotic Drug SQ641 (pdf)
  

• August 2008

  Pathogen that Causes Disease in Cattle Also Associated with Crohn’s Disease – Research Urgently Needed to Evaluate Potential Risks to Humans (pdf)

• July 2008

  Sequella Receives NIH Grant for B-SMART™ Program (pdf)

  Camping out for biotech tax credits

• June 2008

  Sequella, Inc. Selected to Present at the 2008 BIO International Convention (pdf)

• April 2008

  Sequella Celebrates a Decade Of Success — Science Highlights Include Advances in Tuberculosis Detection and Treatment (pdf)

• March 2008

  NIAID Statement on World Tuberculosis Day (pdf)